Timothy M. Wright
Président chez Kling Biotherapeutics BV
Profil
Timothy M.
Wright is currently the Chairman at Kling Biotherapeutics BV, an Independent Director at ENYO Pharma SA, a Member-Supervisory Board at CureVac SE, and a General Partner at Time Bioventures.
He previously served as an Independent Director at Schrödinger, Inc., Senior Director-Clinical Sciences at Pfizer GmbH, Assistant Professor at the University of Pittsburgh Medical Center, Global Head-Pharma Development at Novartis Pharmaceuticals Corp., Chief Research & Development Officer at Regulus Therapeutics, Inc., Assistant Professor at The Johns Hopkins University School of Medicine, Executive Vice President-Translational Sciences at California Institute for Biomedical Research, and a Member-Supervisory Board at CureVac NV.
Dr. Wright received his undergraduate degree from the University of Delaware and his doctorate from The Johns Hopkins University School of Medicine.
Postes actifs de Timothy M. Wright
| Sociétés | Poste | Début |
|---|---|---|
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Directeur/Membre du Conseil | - |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Directeur/Membre du Conseil | 24/06/2019 |
Time Bioventures
 Time Bioventures Investment ManagersFinance Time Bioventures (Time Bioventures) is a venture capital firm founded in 2019 by D.A. Wallach. The firm is headquartered in Los Angeles, California. | Private Equity Investor | 01/04/2019 |
Kling Biotherapeutics BV
 Kling Biotherapeutics BV BiotechnologyHealth Technology Kling Biotherapeutics BV is a clinical-stage biotechnology company based in the Netherlands. The Dutch company has developed a pipeline that evaluates B cells in individuals with remarkable responses to cancer and infectious diseases. Kling Biotherapeutics' proprietary B cell immortalization platform enables rapid functional screening of antibodies, leading to the identification of several antibodies targeting novel epitopes and cancer-associated antigens with unique post-translational modifications. Michael Koslowski has been the CEO of the company since 2022. | Président | - |
Anciens postes connus de Timothy M. Wright
| Sociétés | Poste | Fin |
|---|---|---|
| CUREVAC N.V. | Directeur/Membre du Conseil | 24/06/2021 |
| SCHRÖDINGER, INC. | Directeur/Membre du Conseil | 17/06/2021 |
| REGULUS THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 15/03/2019 |
California Institute for Biomedical Research
 California Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services The California Institute for Biomedical Research provides biomedical research services. The non-profit company is based in La Jolla, CA. | Corporate Officer/Principal | 01/01/2016 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2015 |
Formation de Timothy M. Wright
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SCHRÖDINGER, INC. | Technology Services |
| REGULUS THERAPEUTICS INC. | Health Technology |
| CUREVAC N.V. | Health Technology |
| Entreprise privées | 8 |
|---|---|
California Institute for Biomedical Research
California Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services The California Institute for Biomedical Research provides biomedical research services. The non-profit company is based in La Jolla, CA. | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Time Bioventures
Time Bioventures Investment ManagersFinance Time Bioventures (Time Bioventures) is a venture capital firm founded in 2019 by D.A. Wallach. The firm is headquartered in Los Angeles, California. | Finance |
| Pfizer GmbH | |
University of Pittsburgh Medical Center
 University of Pittsburgh Medical Center Medical/Nursing ServicesHealth Services University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA. | Health Services |
Kling Biotherapeutics BV
Kling Biotherapeutics BV BiotechnologyHealth Technology Kling Biotherapeutics BV is a clinical-stage biotechnology company based in the Netherlands. The Dutch company has developed a pipeline that evaluates B cells in individuals with remarkable responses to cancer and infectious diseases. Kling Biotherapeutics' proprietary B cell immortalization platform enables rapid functional screening of antibodies, leading to the identification of several antibodies targeting novel epitopes and cancer-associated antigens with unique post-translational modifications. Michael Koslowski has been the CEO of the company since 2022. | Health Technology |
